NCT00004050View on ClinicalTrials.gov

Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

Leuvectin

Leuvectin injected intratumorally followed by prostatectomy

Trial Locations (2)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors

Lead Sponsor

Vical
All Listed Sponsors
collaborator

Jonsson Comprehensive Cancer Center

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Vical

INDUSTRY